Cite
APA Citation
Zenger, C., Hong, S. J., Pecoriello, J., Pang, A. S., Vallely, M., Hudesman, D., Chang, S., & Axelrad, J. (n.d.). s961 Risk of New or Recurrent Cancer After Vedolizumab or Ustekinumab Exposure in Patients With Inflammatory Bowel Disease and Previous Cancer. American journal of gastroenterology, 116, S460. http://access.bl.uk/ark:/81055/vdc_100144523636.0x000059